# Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients

> **NCT01174823** · PHASE2 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 245 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** bepotastine besilate ophthalmic solution
- **DRUG:** placebo comparator ophthalmic solution

## Key facts

- **NCT ID:** NCT01174823
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-10
- **Final completion:** 2010-12
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2020-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174823, "Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01174823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*